- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01603524
Integrating the "Ottawa Model" for Smoking Cessation Into Primary Care Practice (RCT-OMSC-PC)
Integrating the "Ottawa Model" for Smoking Cessation Into Routine Primary Care Practice: A Cluster Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Y 4W7
- University of Ottawa Heart Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Practice Inclusion Criteria:
- Is a primary care practice (family health team, family health group, family health network, community health centre);
- Has a minimum of five full time physicians on staff or sees an average of 50 patients per day;
- All physicians within the practice are willing to participate in the study.
Practice Exclusion Criteria:
- Primary care practices with less than 5 family physicians in a shared clinic space will be excluded.
- Clinics who have already implemented the OMSC will also be excluded.
Patient Inclusion Criteria:
- Current smoker (>5 cigarette per day on most days of the week);
- 18 years of age or older;
- Scheduled for an annual exam or non-urgent medical appointment with a physician or nurse practitioner;
- Able to read and understand English or French;
- Has a home or mobile telephone which can be used to receive follow-up telephone counselling calls;
- Has the mental capacity to provide informed consent and complete study protocols.
Patient Exclusion Criteria:
- Unable to read and understand English or French;
- Do not have a home or mobile telephone which can be used to receive follow-up calls;
- Do not have the mental capacity to provide informed consent and complete study protocols.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: OMSC Group
The OMSC Group will receive a multi-component intervention which includes:
|
The OMSC Group will receive a multi-component intervention which includes:
The OMSC + Performance Feedback Group will receive the same intervention program as the OMSC group.
In addition, clinicians will complete a one-hour audit and feedback session prior to the implementation of the OMSC program at their clinic.
The goal of the audit and feedback is to increase provider self-efficacy in the delivery of smoking cessation interventions, raise awareness of the current delivery of evidence-based cessation practices, identify areas for improvement, and motivate providers to deliver evidence-based treatments.
|
|
Experimental: OMSC + Performance Feedback Group
The OMSC + Provider Performance Feedback Group will receive the same intervention program as the OMSC group.
In addition, clinicians will complete a one-hour audit and feedback session prior to the implementation of the OMSC program at their clinic.
|
The OMSC + Performance Feedback Group will receive the same intervention program as the OMSC group.
In addition, clinicians will complete a one-hour audit and feedback session prior to the implementation of the OMSC program at their clinic.
The goal of the audit and feedback is to increase provider self-efficacy in the delivery of smoking cessation interventions, raise awareness of the current delivery of evidence-based cessation practices, identify areas for improvement, and motivate providers to deliver evidence-based treatments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of the Ottawa Model for Smoking Cessation within family doctors' offices compared to control practices.
Time Frame: Patient bio-chemically verified 7-day point prevalence abstinence is measured at 6 months post-enrollement.
|
The primary objectives of this study are to determine whether the Ottawa Model for Smoking Cessation (OMSC) increases:
|
Patient bio-chemically verified 7-day point prevalence abstinence is measured at 6 months post-enrollement.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Examining the incremental impact of audit and feedback within family doctors' offices compared to the OMSC alone group and standard control practices.
Time Frame: Patient bio-chemically verified 7-day point prevalence abstinence is measured at 6 months post-enrollement.
|
The secondary objectives of this study are to examine the incremental impact of audit and feedback on:
|
Patient bio-chemically verified 7-day point prevalence abstinence is measured at 6 months post-enrollement.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sophia Papadakis, Ph.D., MHA, University of Ottawa Heart Insitute
Publications and helpful links
General Publications
- Reid RD, Mullen KA, Slovinec D'Angelo ME, Aitken DA, Papadakis S, Haley PM, McLaughlin CA, Pipe AL. Smoking cessation for hospitalized smokers: an evaluation of the "Ottawa Model". Nicotine Tob Res. 2010 Jan;12(1):11-8. doi: 10.1093/ntr/ntp165. Epub 2009 Nov 10.
- Papadakis S, McDonald P, Mullen KA, Reid R, Skulsky K, Pipe A. Strategies to increase the delivery of smoking cessation treatments in primary care settings: a systematic review and meta-analysis. Prev Med. 2010 Sep-Oct;51(3-4):199-213. doi: 10.1016/j.ypmed.2010.06.007. Epub 2010 Jun 17.
- McIvor A, Kayser J, Assaad JM, Brosky G, Demarest P, Desmarais P, Hampson C, Khara M, Pathammavong R, Weinberg R. Best practices for smoking cessation interventions in primary care. Can Respir J. 2009 Jul-Aug;16(4):129-34. doi: 10.1155/2009/412385.
- Papadakis S, Pipe AL, Reid RD, Tulloch H, Mullen KA, Assi R, Cole AG, Wells G. Effectiveness of performance coaching for enhancing rates of smoking cessation treatment delivery by primary care providers: Study protocol for a cluster randomized controlled trial. Contemp Clin Trials. 2015 Nov;45(Pt B):184-190. doi: 10.1016/j.cct.2015.08.013. Epub 2015 Sep 5.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2011583-01H
- NA 7193 (Other Grant/Funding Number: Heart and Stroke Foundation of Canada)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
The University of Hong KongCompletedSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
Clinical Trials on OMSC Group
-
Ottawa Heart Institute Research CorporationActive, not recruitingTobacco Smoking | VapingCanada
-
Tanta UniversityCompletedChildren | Dexmedetomidine | Adenotonsillectomy | MidazolamEgypt
-
Tanta UniversityNot yet recruitingMelatonin | Doxorubicin | Vitamin D Concentration | Breast Cancer Patients DiagnosedEgypt
-
Charite University, Berlin, GermanyDepartment of Neurology, Charité - Universitätsmedizin Berlin, Germany; Department...Unknown
-
University of Sao Paulo General HospitalCompletedOsteoarthritis, Knee
-
National Yang Ming Chiao Tung UniversityCompleted
-
Chang Gung UniversityCompleted
-
Ankara City Hospital BilkentCompletedFrailty | Colonoscopy | Sedation | Cognition | Geriatric AnesthesiaTurkey (Türkiye)
-
Karaman Training and Research HospitalCompleted
-
Cairo UniversityCompleted